Kuleon Bio
Küleon is a drug discovery company leveraging proprietary, AI-based technology to identify novel serotonergic drugs for the targeted treatment of various neuropsychiatric diseases and disorders. Küleon developed a portfolio of serotonin receptor ligands to target brain abnormalities in disorders like schizophrenia and depression. They found promising preclinical leads with improved characteristics compared to other drugs.
Expertise
- Brand Strategy
- Web Design & Development
Deliverables
- Brand Identity
- Branding Guide & Collateral
- Website
Website
Our Execution
We worked with Küleon to establish a digital presence along with a solidified Brand identity on this ground-breaking project. The goal was to create a digital presence that targets industry leaders in the Neuropsychiatric Medical space to educate and promote the unique compounds and developmental technology Küleon offers. We helped develop the brand's complete visual ownership of this technology within the Neuropsychiatric Medical space. We also created a new way of representing technical molecular structures in a unique and creative aesthetic.
